Raymond James & Associates Covetrus, Inc. Transaction History

Raymond James & Associates

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$13.8 - $20.82 $240,258 - $362,476	17,410 New	17,410 $361,000
Q1 2022 May 11, 2022	SELL	$15.96 - $18.87 $686,184 - $811,296	-42,994 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$16.79 - $20.37 $260,412 - $315,938	-15,510 Reduced 26.51%	42,994 $859,000
Q3 2021 Nov 02, 2021	SELL	$18.14 - $27.03 $908,814 - $1.35 Million	-50,100 Reduced 46.13%	58,504 $1.06 Million
Q2 2021 Aug 11, 2021	BUY	$25.24 - $30.86 $37,456 - $45,796	1,484 Added 1.39%	108,604 $2.93 Million
Q1 2021 May 14, 2021	BUY	$28.29 - $39.89 $479,685 - $676,374	16,956 Added 18.81%	107,120 $3.21 Million
Q4 2020 Feb 12, 2021	BUY	$24.45 - $31.59 $387,777 - $501,017	15,860 Added 21.34%	90,164 $2.59 Million
Q3 2020 Nov 04, 2020	BUY	$17.22 - $24.59 $856,126 - $1.22 Million	49,717 Added 202.21%	74,304 $1.81 Million
Q2 2020 Jul 28, 2020	BUY	$6.46 - $19.27 $3,843 - $11,465	595 Added 2.48%	24,587 $440,000
Q1 2020 Apr 21, 2020	BUY	$5.64 - $15.23 $23,614 - $63,768	4,187 Added 21.14%	23,992 $195,000
Q4 2019 Feb 12, 2020	SELL	$8.8 - $14.93 $406,190 - $689,138	-46,158 Reduced 69.98%	19,805 $261,000
Q3 2019 Nov 07, 2019	SELL	$11.76 - $25.57 $998,376 - $2.17 Million	-84,896 Reduced 56.28%	65,963 $784,000
Q2 2019 Aug 06, 2019	BUY	$22.88 - $33.27 $1.31 Million - $1.9 Million	57,232 Added 61.13%	150,859 $3.69 Million
Q1 2019 May 06, 2019	BUY	$31.52 - $46.19 $2.95 Million - $4.32 Million	93,627 New	93,627 $2.98 Million

72.9K

Ticker CVET
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 140,123,008
Description
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.